Literature DB >> 18258987

Locally advanced and inflammatory breast cancer.

Stephen Chia1, Sandra M Swain, David R Byrd, David A Mankoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18258987     DOI： 10.1200/JCO.2008.15.0243

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  54 in total

1.  Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging.

Authors:  V Girardi; G Carbognin; L Camera; F Bonetti; E Manfrin; G Pollini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Breast Cancer in Special Situations.

Authors:  Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

3.  A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.

Authors:  Lale Kostakoglu; Fenghai Duan; Michael O Idowu; Paul R Jolles; Harry D Bear; Mark Muzi; Jean Cormack; John P Muzi; Daniel A Pryma; Jennifer M Specht; Linda Hovanessian-Larsen; John Miliziano; Sharon Mallett; Anthony F Shields; David A Mankoff
Journal:  J Nucl Med       Date:  2015-09-10       Impact factor: 10.057

4.  Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response.

Authors:  Malathy P V Shekhar; Laura A Biernat; Nat Pernick; Larry Tait; Judith Abrams; Daniel W Visscher
Journal:  Med Oncol       Date:  2009-05-23       Impact factor: 3.064

5.  Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

Authors:  Raphael Richard; Isabelle Thomassin; Marion Chapellier; Aurélie Scemama; Patricia de Cremoux; Mariana Varna; Sylvie Giacchetti; Marc Espié; Eric de Kerviler; Cedric de Bazelaire
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

6.  Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

Authors:  Kazuhiro Kitajima; Koya Nakatani; Kazushige Yamaguchi; Masatoyo Nakajo; Atsushi Tani; Mana Ishibashi; Keiko Hosoya; Takahiro Morita; Takayuki Kinoshita; Hayato Kaida; Yasuo Miyoshi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-12       Impact factor: 9.236

7.  Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.

Authors:  Prasant Yadav; Masroor Mirza; Kajal Nandi; S K Jain; R C M Kaza; Nita Khurana; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-09-30

8.  Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report.

Authors:  Isabel Reis; Helena Pereira; Isabel Azevedo; João Conde; Isabel Bravo; Rogéria Craveiro; Deolinda Pereira
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-20

9.  High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.

Authors:  Takahiro Kogawa; Tamer M Fouad; Diane D Liu; Jimin Wu; Yu Shen; Hiroko Masuda; Takeo Fujii; Mariana Chavez-MacGregor; Ricardo H Alvarez; Gabriel N Hortobágyi; Vicente Valero; Naoto T Ueno
Journal:  Oncologist       Date:  2015-12-09

10.  Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  Alberto Alvarado-Miranda; Oscar Arrieta; Carlos Gamboa-Vignolle; David Saavedra-Perez; Rafael Morales-Barrera; Enrique Bargallo-Rocha; Juan Zinser-Sierra; Victor Perez-Sanchez; Teresa Ramirez-Ugalde; Fernando Lara-Medina
Journal:  Radiat Oncol       Date:  2009-07-11       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.